185 related articles for article (PubMed ID: 36534351)
21. Association between primary Sjogren's syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis.
Yong WC; Sanguankeo A; Upala S
Clin Rheumatol; 2019 Feb; 38(2):447-455. PubMed ID: 30178172
[TBL] [Abstract][Full Text] [Related]
22. Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.
Bolstad AI; Le Hellard S; Kristjansdottir G; Vasaitis L; Kvarnström M; Sjöwall C; Johnsen SJ; Eriksson P; Omdal R; Brun JG; Wahren-Herlenius M; Theander E; Syvänen AC; Rönnblom L; Nordmark G; Jonsson R
Ann Rheum Dis; 2012 Jun; 71(6):981-8. PubMed ID: 22294627
[TBL] [Abstract][Full Text] [Related]
23. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
Lee YH; Kim JH; Song GG
Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
[TBL] [Abstract][Full Text] [Related]
24. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for Sjögren's syndrome: a case-control study.
Priori R; Medda E; Conti F; Cassarà EA; Sabbadini MG; Antonioli CM; Gerli R; Danieli MG; Giacomelli R; Pietrogrande M; Valesini G; Stazi MA
Clin Exp Rheumatol; 2007; 25(3):378-84. PubMed ID: 17631733
[TBL] [Abstract][Full Text] [Related]
26. Association of CD28 and CTLA4 haplotypes with susceptibility to primary Sjögren's syndrome in Mexican population.
López-Villalobos EF; Carrillo-Ballesteros FJ; Muñoz-Valle JF; Palafox-Sánchez CA; Valle Y; Orozco-Barocio G; Oregon-Romero E
J Clin Lab Anal; 2019 Jan; 33(1):e22620. PubMed ID: 29992636
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
Lin W; Xin Z; Ning X; Li Y; Ren X; Su Y; Liu M; Guo S; Yang L; Liu Y; Zhang F; Zhang W
Clin Rheumatol; 2021 Oct; 40(10):4081-4087. PubMed ID: 33914202
[TBL] [Abstract][Full Text] [Related]
28. TNFSF4 is a risk factor for rheumatoid arthritis but not for primary Sjögren's syndrome in the Mexican population.
Ramírez-Bello J; Jiménez-Morales S; Barbosa-Cobos RE; Sánchez-Zauco N; Hernández-Molina G; Luria-Pérez R; Fragoso JM; Cabello-Gutiérrez C; Montúfar-Robles I
Immunobiology; 2022 Jul; 227(4):152244. PubMed ID: 35835012
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
[TBL] [Abstract][Full Text] [Related]
30. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
Bartoloni E; Baldini C; Schillaci G; Quartuccio L; Priori R; Carubbi F; Bini V; Alunno A; Bombardieri S; De Vita S; Valesini G; Giacomelli R; Gerli R
J Intern Med; 2015 Aug; 278(2):185-92. PubMed ID: 25582881
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of clinical features and prognosis in patients with primary Sjögren's syndrome and autoimmune liver disease].
Chen WQ; Dai XN; Yu Y; Wang Q; Liang JY; Ke YN; Yi CH; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):886-891. PubMed ID: 33047724
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune disease aggregation in families with primary Sjögren's syndrome.
Anaya JM; Tobon GJ; Vega P; Castiblanco J
J Rheumatol; 2006 Nov; 33(11):2227-34. PubMed ID: 17086607
[TBL] [Abstract][Full Text] [Related]
34. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
Zhu T; Pan Z; Zhang N
Clin Rheumatol; 2022 Sep; 41(9):2791-2802. PubMed ID: 35616754
[TBL] [Abstract][Full Text] [Related]
35. BLK and BANK1 variants and interactions are associated with susceptibility for primary Sjögren's syndrome and with some clinical features.
Montúfar-Robles I; Lara-García S; Barbosa-Cobos RE; Vargas-Alarcón G; Hernández-Molina G; Fragoso JM; Cabello-Gutiérrez C; Reyes-Cetina IL; Arenas-Silva I; Cruz-Mayor KJ; Concha-Del Río LE; De Anda-Turati M; Sánchez-Tlapalcoyoatl A; Cheja-Kalb R; Hubbe-Tena C; Lima G; Mendoza-Rincón JF; Ramírez-Bello J
Cell Immunol; 2021 May; 363():104320. PubMed ID: 33756160
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
Imgenberg-Kreuz J; Sandling JK; Almlöf JC; Nordlund J; Signér L; Norheim KB; Omdal R; Rönnblom L; Eloranta ML; Syvänen AC; Nordmark G
Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
[TBL] [Abstract][Full Text] [Related]
37. Cigarette smoking patterns preceding primary Sjögren's syndrome.
Mofors J; Björk A; Richardsdotter Andersson E; Kvarnström M; Forsblad d'Elia H; Magnusson-Bucher S; Padyukov L; Kockum I; Hillert J; Eriksson P; Mandl T; Nordmark G; Alfredsson L; Wahren-Herlenius M
RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994363
[TBL] [Abstract][Full Text] [Related]
38. Risk of subclinical atherosclerosis in primary Sjogren's syndrome: A systematic review and meta-analysis.
Karakasis P; Patoulias D; Pamporis K; Stachteas P; Lefkou E; Bougioukas KI; Dimitroulas T; Fragakis N
Eur J Intern Med; 2024 Apr; 122():93-101. PubMed ID: 37977997
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of primary Sjögren's syndrome in male and paediatric populations.
Virdee S; Greenan-Barrett J; Ciurtin C
Clin Rheumatol; 2017 Oct; 36(10):2225-2236. PubMed ID: 28735431
[TBL] [Abstract][Full Text] [Related]
40. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
